Termination of paroxysmal supraventricular tachycardia with oral diltiazem
1Johnson County Internal Medicine Associates, Inc., Franklin, IN 46131-2190.
Abstract:
Patients with paroxysmal supraventricular tachycardia (PSVT) who are either not adequately controlled with chronic suppressive therapy or who have infrequent attacks may be treated with oral diltiazem with a high probability of conversion to sinus rhythm within 30 minutes of ingestion of the calcium channel blocker. Due to its rapid absorption, the diltiazem appears to be effective in converting PSVT and may eliminate the need for emergency department evaluation and parenteral drug therapy.
More Related Videos
Related Concept Videos
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Dysrhythmias II: Classification of Tachyarrhythmias
Dysrhythmias VI: Management of Dysrhythmias
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias


